✦ LIBER ✦

Approvals And Market Discontinuations Of Oncology Drugs In The United States (1980-2012)

✍ Scribed by Turkistani, F.A.; Greene, N.; Seoane-Vazquez, E.; Rodriguez-Monguio, R.; Szeinbach, S.L.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

DH4 MARKET DISCONTINUATION OF PHARMACEUT

✍ ZP Oureshi; SL Szeinbach; E Seoane-Vazquez 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 62 KB

PHP16 MARKET DISCONTINUATION OF PHARMACE

✍ ZP Qureshi; SL Szeinbach; E Seoane-Vazquez; R Rodriguez-Monguio 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 119 KB

Post-marketing surveillance of approved

✍ Nichol, F.Richard; Pickering, B.I.; Bollert, J.A. 📂 Article 📅 1980 🏛 Elsevier Science 🌐 English ⚖ 69 KB

FD2 ORPHAN DRUGS' MARKET ACCESS IN THE U

✍ JJ Doyle; B Sepulveda 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

Drug discontinuations in the United King

✍ Bakke, Olav M; Wardell, William M; Lasagna, Louis 📂 Article 📅 1984 🏛 Nature Publishing Group 🌐 English ⚖ 647 KB

How Do Oncology Drug Prices Vary Across

✍ Patel, P.; Donze, B.; Zaganelli, D. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 74 KB